| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.32 | 1e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.36 | 3e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.3 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 0.0006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.19 | 0.006 |